Skip to content

Axcess News – Lifestyle

Author: Knight Therapeutics

Knight Therapeutics Announces Regulatory Submission of NIKTIMVO® (Axatilimab) in Brazil

March 4, 2026

←Previous Page

1 2

All content ©2025 Tork Media
All Rights Reserved. For more information on this site, please read our Privacy Policy, Terms of Service, Cookie Policy, and Ad Choices.